Human leukocyte antigens and cytokine expression in cerebral inflammatory demyelinative lesions of X-linked adrenoleukodystrophy and multiple sclerosis

Journal of Neuroimmunology

Volumn 75, Issue 1-2, 1997, Pages 174-182

  McGuinness, M C ^a,b   Powers, J M ^c   Bias, W B ^b   Schmeckpeper, B J ^b   Segal, A H ^a   Gowda, V C ^a   Wesselingh, S L ^b   Berger, J ^d   Griffin, D E ^b   Smith, K D ^a,b  

^a KENNEDY KRIEGER INSTITUTE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

cytokines; human leukocyte antigens; multiple sclerosis; tumor necrosis factor ; X linked adrenoleukodystrophy

Indexed keywords

GAMMA INTERFERON; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADRENOLEUKODYSTROPHY; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; GENE EXPRESSION; HLA SYSTEM; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; X CHROMOSOME LINKAGE;

ADRENOLEUKODYSTROPHY; BLOOD CELLS; CYTOKINES; DEMYELINATING DISEASES; ENCEPHALITIS; HLA ANTIGENS; HUMANS; LYMPHOCYTES; MULTIPLE SCLEROSIS; TISSUE DISTRIBUTION; TUMOR NECROSIS FACTOR-ALPHA; X CHROMOSOME;

EID: 0030975326     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(97)00020-9     Document Type: Article

References (44)

1. Amos, D.B., Bashir, H., Boyle, W., MacQueen, M. and Tiilikainen, A. (1969) A simple microtoxicity test. Transplantation 7, 220-222.
2. Berger, J., Molzer, B., Fae, I. and Bernheimer, H. (1994) X-linked adrenoleukodystrophy (ALD) - a novel mutation of the ALD gene in 6 members of a family presenting with 5 different phenotypes. Biochem. Biophys. Res. Commun. 205, 1638-1643.
3. Berger, J., Bernheimer, H., Fae, I., Braun, A., Roscher, A., Molzer, B. and Fischer, G. (1995) Association of X-linked adrenoleukodystrophy with HLA DRB1 alleles. Biochem. Biophys. Res. Commun. 216, 447-451.
4. Beutler, B., Krochin, N., Milsark, I.W., Luedke, C. and Cerami, A. (1986) Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. Science 232, 977-980.
5. Bias, W.B., Hsu, S.H. Pollard, M.K., Harvey, J., Lotze, M.T., Arnett, F.C. and Stevens. M.B. (1981) HLA-DR characterization of a Chippewa Indian subpopulation with high prevalence of rheumatoid arthritis. Hum. Immunol. 2, 155-163.
6. Bizzozero, O.A., Zuniga, G. and Lees, M.B. (1991) Fatty acid composition of human myelin proteolipid protein in peroxisomal disorders. J. Neurochem. 56, 872-878.
7. Boles, D.J., Craft, D.A., Padgett, D.A., Loria, R.M. and Rizzo, W.B. (1991) Clinical variation in X-linked adrenoleukodystrophy: fatty acid and lipid metabolism in cultured fibroblasts. Biochem. Med. Metab. Biol. 45, 74-91.
8. Cannella, B. and Raine, C.S. (1995) The adhesion molecule and cytokine profile of multiple sclerosis lesions. Ann. Neurol. 37, 424-435.
9. Dunn, O.J. (1958) Estimation of the means of dependent variables. Ann. Math. Stat. 29, 1095-1111.
10. Dunn, O.J. (1961) Multiple comparisons among means. Am. J. Stat. Assoc. 56, 52-64.
11. Freedman, B.I., Spray, B.J., Heise, E.R., Espeland, M.A. and Canzanello, V.J. (1993) A race-controlled human leukocyte antigen frequency analysis in lupus nephritis. The South-Eastern Organ Procurement Foundation. Am. J. Kidney Dis. 21, 378-382.
12. Gieselmann, V., Zlotogora, J., Harris, A., Wenger, D.A. and Philip Morris, C. (1994) Molecular genetics of metachromatic leukodystrophy. Human Mut. 4, 233-242.
13. Griffin, D.E., Moser, H.W., Mendoza, Q., Moench, T.R., O'Toole, S. and Moser, A.B. (1985) Identification of the inflammatory cells in the nervous system of patients with adrenoleukodystrophy in multiple sclerosis brain. Ann. Neurol. 18, 660-664.
14. Hillaert, J. (1994) Human leukocyte antigen studies in multiple sclerosis. Ann. Neurol. 36, S15-S17.
15. Hofman, F.M., van Hanwehr, R.I., Dinarello, C.A., Mizel, S.B., Hinton, D. and Merril, J.E. (1986) Immunoregulatory molecules and IL-2 receptors identified in multiple sclerosis brain. J. Immunol. 136, 3239-3245.
16. Hofman, F.M., Hinton, D.R., Johnson, K. and Merrill, J.E. (1989) Tumor necrosis factor identified in multiple sclerosis brain. J. Exp. Med. 170, 607-610.
17. Igarashi, M., Schaumburg, H.H., Powers, J., Kishimoto, Y., Kolodny, E. and Suzuki, K. (1976a) Fatty acid abnormality in adrenoleukodystrophy. J. Neurochem. 26, 851-860.
18. Igarashi, M., Belchis, D. and Suzuki, K. (1976b) Brain gangliosides in adrenoleukodystrophy. J. Neurochem. 27, 327-328.
19. Kaldy, P. and Schmitt-Verhulst, A.M. (1995) Regulation of interferon-gamma mRNA in a cytolytic T cell clone; Ca(2+)-induced transcription followed by mRNA stabilization through activation of protein kinase C or increase in cAMP. Eur. J. Immunol. 25, 889-895.
20. Kemp, S., Ligtenberg, J.L., Van Geel, B.M., Barth, P.G., Wolterman, R.A., Schoute, F., Sarde, C.O., Mandel, J.L., van Oost, B.A. and Bolhuis, P.A. (1994) Identification of a two base pair deletion in five unrelated families with adrenoleukodystrophy: A possible hot spot for mutations. Biochem. Biophys. Res. Commun. 202, 647-653.
21. Kimura, A. and Sasazuki, T. (1991) Eleventh International Histocompatibility Workshop reference protocol for the HLA DNA typing technique. In: ed. K. Tsuji, M. Aizawa and T. Sasazuki, Proc. of the 11th Int. Histocompatibility Workshop and Conf., Vol. 1, pp. 397-419.
22. Kishimoto, Y., Moser, H.W. and Suzuki, K. (1984) Neurochemistry of adrenoleukodystrophy. In: ed. A. Lajtha, The Handbook of Neurochemistry, Vol. 10. Plenum, New York, pp. 125-151.
23. Kok, F., Neumann, S., Sarde, C.O., Zheng, S., Wu, K.H., Wei, H.M., Bergin, J., Watkins, P.A., Gould, S., Sack, G., Moser, H., Mandel, J.L. and Smith, K.D. (1995) Mutational analysis of patients with X-linked adrenoleukodystrophy. Hum. Mutat. 6, 104-115.
24. Kumar, A.J., Kohler, W., Kruse, B., Naidu, S., Bergin, A. and Moser, H.W. (1995) MR findings in adult-onset adrenoleukodystrophy. Amer. J. Neuroradiol. 16, 1227-1237.
25. McGuinness, M.C., Griffin, D.E., Raymond, G.V., Washington, C.A., Moser, H.W. and Smith, K.D. (1995) Tumor necrosis factor-α and X-linked adrenoleukodystrophy. J. Neuroimmunol. 61, 161-169.
26. Moreira, A.L., Sampaio, E.P., Zmuidzinas, A., Frindt, P., Smith, K.A. and Kaplan, G. (1993) Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation. J. Exp. Med. 177, 1675-1680.
27. Moser, H.W., Moser, A.B., Smith, K.D., Bergin, A., Borel, J., Shankroff, J., Stine, O., Merette, C., Ott, J., Krivit, W., Shapiro, E. (1992) Adrenoleukodystrophy: Phenotypic variability: Implications for therapy. J. Inher. Met. Dis. 15, 645-664.
28. Moser, H.W., Smith, K.D. and Moser, A.B. (1995) X-linked adrenoleukodystrophy. In: eds. C.R. Scriver, A.L. Beudet, W.S. Sly and D. Valle, The Metabolic Basis of Inherited Disease, 7th Ed. McGraw-Hill, New York, pp. 4256-4300.
29. Mosser, J., Douar, A.M., Sarde, C.O., Kioschis, P., Feil, R., Moser, H., Poustka, A.M., Mandel, J.L., Aubourg, P. (1993) Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters. Nature 361, 726-730.
30. Mosser, J., Lutz, Y., Stoeckel, M.E., Sarde, C.O., Kretz, C., Douar, A.M., Lopez, J., Aubourg, P. and Mandel, J.L. (1994) The gene responsible for adrenoleukodystrophy encodes a peroxisomal membrane protein. Hum. Mol. Genet. 3, 265-71.
31. Nepom, G.T. and Nepom, B.S. (1992) Prediction of susceptibility to rheumatoid arthritis by human leukocyte antigen genotyping. [Review] Rheum. Dis. Clin. North Am. 18, 785-792.
32. Powers, J.M., Liu, Y., Moser, A.B. and Moser, H.W. (1992) The inflammatory myelinopathy of adreno-leukodystrophy; cells, effector molecules, and pathogenic implications. J. Neuropath. Exp. Neurol. 51, 630-643.
33. Schaumburg, H.H., Powers, J.M., Raine, C.S., Suzuki, K. and Richardson, E.P., Jr. (1975) Adrenoleukodystrophy. A clinical and pathological study of 17 cases. Arch. Neurol. 33, 577-591.
34. Selmaj, K.W. and Raine, C.S. (1988) Tumor necrosis factor mediated myelin and oligodendrocyte damage in vitro. Ann Neurol. 23, 339-346.
35. Selmaj, K., Raine, C.S., Cannella, B. and Brosnan, C.F. (1991) Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J. Clin. Invest. 87, 949-954.
36. Smith, K.D., Sack, G., Beaty, T., Bergin, A., Naidu, S., Moser, A. and Moser, H.W. (1991) A genetic basis for the multiple phenotypes of X-linked adrenoleukodystrophy. Am. J. Hum. Gen. 49 (suppl), 165.
37. Theda, C., Moser, A.B., Powers, J.M. and Moser, H.W. (1992) Phospholipids in X-linked adrenoleukodystrophy white matter: fatty acid abnormalities before the onset of demyelination. J. Neur. Sci. 110, 195-204.
38. Tyor, W.R., Glass, J.D., Baumrind, N., McArthur, J.C., Griffin, J.W., Becker, P.S. and Griffin, D.E. (1993) Cytokine expression of macrophages in HIV-1-associated vacuolar myelopathy. Neurology 43, 1002-1009.
39. Van Rood, J.J., van Leeuwen, A. and Ploem, J.S. (1976) Simultaneous detection of two cell populations by two color fluorescence and application to the recognition of B-cell determinants. Nature 262, 795-797.
40. Waksman, B.H. (1985) Mechanisms in multiple sclerosis. Nature 318, 104-105.
41. Watkins, P.A., Gould, S.J., Smith, M.A., Braiterman, L.T., Wei, H.M., Kok, F. Moser, A.B., Moser, H.W. and Smith, K.D. (1995) Altered expression of ALDP in X-linked adrenoleukodystrophy. Am. J. Hum. Genet. 57, 292-301.
42. Wesselingh, S.L., Power, C., Glass, D., Tyor, W.R., McArthur, J.C., Farber, J.M., Griffin, J.W. and Griffin, D.E. (1993) Intracerebral cytokine messenger RNA expression in aquired immunodeficiency syndrome dementia. Ann. Neurol. 33, 576-582.
43. Woodroofe, M.N., Bellamy, A.S., Feldman, M., Davison, A.N. and Cuzner, M.L. (1988) Immunocytochemical characterization of the immune reaction in the central nervous system in multiple sclerosis. J. Neurol. Sci. 84, 257-264.
44. Woodroofe, M.N. and Cuzner, M.L. (1993) Cytokine mRNA expression in inflammatory (MS) lesions: detection by non-radioactive in situ hybridization. Cytokine 5, 583-588.